Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07056400

Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
108 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Male
Age
25 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The Aim of the trial: Assess if a consecutive second ejaculate contains an equal, or even higher number of motile sperm and produces high-quality sperm for intracytoplasmic sperm injection (ICSI) in male factor patients and if it will improve clinical outcomes, such as fertilization rate, embryo quality, number of blastocysts retrieved per cycle, implantation, and hopefully pregnancy rates.

Detailed description

Background: According to research, the length of abstinence has an impact on sperm DNA fragmentation (SDF) as well as sperm parameters. Long abstinence period increases the volume of semen and the concentration of sperm, but it will negatively impact motility, viability, and morphology. The second ejaculation of males shows a considerable improvement in total motility and a significant decrease in (SDF) when it is collected within 1 to 3 hours of the first ejaculate. it is essential to ensure the availability of high-quality spermatozoa with second ejaculation to enhance clinical results in ICSI cycles

Conditions

Interventions

TypeNameDescription
PROCEDUREFirst Ejaculate for ICSIIntervention 1: First Ejaculate for ICSI In this intervention, sperm collected from the first ejaculate will be used in Intracytoplasmic Sperm Injection (ICSI). The sperm will be analyzed for motility, morphology, and concentration before being used in fertilization and embryo culture. This arm will evaluate the quality of sperm obtained from the first ejaculate
PROCEDURESecond Ejaculate for ICSIIn this intervention, sperm collected from the second ejaculate (obtained within 1-2 hours after the first ejaculate) will be used in Intracytoplasmic Sperm Injection (ICSI). The sperm will be analyzed for motility, morphology, and concentration before being used for fertilization and embryo culture. This arm will evaluate the quality of sperm obtained from the second ejaculate and its impact on fertilization rates and embryo development

Timeline

Start date
2024-04-03
Primary completion
2025-12-01
Completion
2026-01-31
First posted
2025-07-09
Last updated
2026-01-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07056400. Inclusion in this directory is not an endorsement.